2020 Flashcards
How many youth who use cannabis will develop problematic cannabis use?
A) 1/4
B) 1/6
C) 1/8
D) 1/10
1/6 of youth will develop problematic cannabis use
Which of these statements is false?
A) Cannabis use before age 14 and using it at least monthly is strongly associated with adverse health impacts
B) In a recent Canadian survey, 20% of youth aged 16-19 reported using cannabis in the previous year
C) There is no clear evidence to support using medications to manage withdrawal symptoms or help adolescents with cannabis use disorder decrease use or quit
D) Those who have a family history of psychosis and depression should avoid using cannabis completely
Answer:
B) In a recent Canadian survey, 44% of youth aged 16 to 19 reported using cannabis within the previous year
Which of these statements is incorrect?
- Teens can be convicted for posessing and distributing child pornography, even when the picture they are sending is of themselves
- All sexually active youth under 25 should be offered annual STI screening
- A 14 year old can consent to sex with a 19 year old
- Mid stream urine, urethral or cervical swab or self collected vaginal swab are all appropriate specimens for chlamydia and gonorrhea testing
Mid stream urine, urethral or cervical swab or self collected vaginal swab are all appropriate specimens for chlamydia and gonorrhea testing
Should be first catch urine
What are the 7 P’s of a sexual health assessment?
‘7 Ps’: Partners, Practices, Protection from sexually transmitted infections (STIs), Past history of STIs, Prevention of pregnancy, Permission (consent), and Personal (gender) identity
Which is not a risk factor for STIs?
A. Any drug use
B. Serial monogamy
C. >2 partners in the past year
D. Street involvement
E. All of the above are risk factors for STIs
E - all are risk factors
Which statement is incorrect?
A. LGBTQ+ youth are at increased risk for STIs and susbtance use
B. A pregnancy test should be done if a sexually active youth has not had their period for more than 4 weeks or does not recall the last menstrual period
C. An anal swab should be done for chlamydia and gonorrhea in those who report receptive anal intercourse
D. G+C, syphilis, HIV, Hep A/B/C should be in routine STI screening for all sexually active youth
D. G+C, syphilis, HIV, Hep A/B/C should be in routine STI screening for sexually active youth
Offer G+C, syphilis, HIV for all sexually active youth
Consider Hep A/B/C serology in those with no or uncertain vaccination history, particularly if oral/anal contact, ir personal or partner history of IV drug use.
True or False: There is clear evidence that Covid-19 can be transmitted via breastmilk.
False: not confirmed.
However 1 systematic review showed 9/84 samples of BM tested + for Covid, 6 infants were exposed and 4 tested +.
But could not confirm this was via BM transmission.
When providing hospital care to Covid + mom and infant: rooming-in should be avoided in initial period. T/F
FALSE.
Mom with ?/+Covid should not be separated form infant
Discussion/SDM (risk/benefit)
and allow for “rooming-in”
What does the CPS statement recommend to minimize risk of transmission of Covid-19 bw mom + baby?
A. Seperate Mom and baby
B. They can room in, but avoid breastfeeding
C. Can breastfeed, however use droplet precautions (mask and hand hygiene)
D. Use alternative method, such as EBM
E. Both C & D
Both C & D
What does CPS recommend to reduce droplet transmission of Covid 19 during breastfeeding?
- Mom should wear mask + hand hygiene before
- Clean breast area w soap + water (if recently coughed/sneezed)
- Use of EBM (cleaning all equipment and common surfaces) is alternative
- Hospitalized mom/baby should also be encouraged to pump/use EBM until BFing established
True or false?
“Pasteurized human donor milk contains the same amount of IgA as non-pasteurized human milk”
False – pasteurization decreases IgA
+ some protein is denatured
folate and vitamin D are degraded
True or false?
“Donors for PHDM are required to be seronegative for hepatitis B, hepatitis C, HIV, HTLV and syphilis”
True or false?
“Given the known benefits of human milk over formula and limited PHDM supply, physicians encourage the families to consider the option of informal unpasteurized donor human milk sharing within their community.”
False
CPS, health Canada, FDA all discourage the practice of informal milk sharing. Formula is considered the safer breast milk substitute for well newborns.
What is the gold standard diagnostic test for congenital CMV?
Urine CMV PCR/shell vial assay (modified culture)
- serology is not recommended due to passive transfer of maternal antibodies
- screening for cCMV is done through newborn screening in Ontario as of July 2019
- Note: CPS statement technically listed saliva CMV PCR in non-breastfed infants as “gold standard” but in another table stated it was just urine CMV PCR/shell vial
When should an infant’s sample be sent for cCMV diagnostic testing?
BEFORE 21 days postnatal age
- if testing is delayed beyond 21 days, it becomes difficult to distinguish between congenital infection vs. perinatally/postnatally acquired infection
What percentage of infants with congenital CMV are asymptomatic?
A) 90%
B) 85%
C) 80%
D) 75%
Answer A) 90%
For pregnant mothers, what interventions are recommended to decrease maternal acquisition of CMV?
A) CMV-specific hyperimmune globulin
B) Antiviral therapy
C) Hygienic measures
D) CMV vaccine
Answer is C = hygienic measures
- CMV-specific hyperimmune globulin & antiviral therapy for pregnant women with primary infection may provide benefit BUT robust evidence supporting this is lacking
- CMV vaccine does not exist at this time
In an infant with suspected to have congental CMV, what would be your next steps in terms of evaluation? (excluding diagnostic testing)
- Labs: CBCD, bili, ALT/AST
- Head imaging: for minimal symptomatic/asymptomatic cases, start with HUS. if neurological symptoms or abnormal HUS, then order MRI
- Optho exam
- hearing test
- +/- ID referral (indications for referral: confirmed symptomatic cases, all cases of cCMV with SNHL (even if asymptomatic). could consider for probable cases)
Which of the following infants would require treatment with anti-virals and what is the typical duration of therapy?
- Infant with SNHL, 6 weeks of tx
- Infants with mod-severe symptoms, 6 weeks of tx
- Infants with mod-severe symptoms, 3 months of tx
- Infant with mod-severe symptoms, 6 months of tx
Answer is 4 - Infant with mod-severe symptoms, 6 months of tx total
- Treatment with anti-retrovirals (typically oral Valgancyclovir) in infants who are severely symptomatic have shown improvement in neurodevelopmental & hearing outcomes for those treated for 6 months (vs 6 weeks)
- If infants are sick, can consider tx with IV Galcyclovir for 2-6 weeks and then transition to Valgancyclovir, for 6 mths total
- Treatment of infants with isolated SNHL is controversial
What are side effects of antiviral therapy that should be monitored closely?
CBCD – Thrombocytopenia, neutropenia (q1wk x 1 mth, q2wk x 2 mths, qmonthly x 3 mths)
AST/ALT – Transaminitis (qmonthly x 6 months)
Urea/Cr – elevation (qmonthly x 6 months)
Congenital CMV infants should be monitored closely. They require:
- Regular audiology, optho follow up
- Regular audiology, optho, neurodevelopmental follow up
- Regular optho, neurodevelopmental follow up
- Regular audiology, optho, neurodevelopmental, and dental follow up
Answer is 4 - regular audiology, optho, neurodevelopmental, and dental follow up
- Sequelae include: microcephaly, severe motor deficits (e.g. CP), intellectual delay, seizures, SNHL, ocular and visual abnormalities
- Symptomatic infants are at risk of dental hypoplasia
A 15-year-old adolescent female is admitted for fever and weakness. She began her most recent menstrual period 3 days ago, and regularly uses tampons. On physical examination she is confused. Vital signs are: temperature 39.4°C, heart rate 150, respiratory rate 24, blood pressure of 80/24. She has diffuse erythroderma and her distal extremities are warm with bounding pulses and rapid CRT. She remains hypotensive despite 60 mL/kg of fluid boluses and initiation of appropriate antibiotics (cloxacillin and clindamycin).
What would be your next step in management?
- Give another bolus of fluid (10 ml/kg)
- Start epinephrine infusion
- Start dopamine infusion
- Start norepinephrine infusion
Answer 4 - start norepinephrine infusion
- this patient is in warm shock - primary goal is to increase systemic vascular resistance
- norepi has strong alpha adrenergic effects –> leading to primarily vasoconstriction
- Epinephrine has effects on alpha adrenergic and beta 1 receptors - would lead to effects on HR, contraction, and vasoconstriction
Which vasoactive medication would you use for each of the following scenarios:
1) cold shock with normal BP
2) cold shock with low BP
3) warm shock with low BP
1) cold shock with normal BP - answer epinephrine 0.03-0.05 mcg/kg/min
2) cold shock with low BP - answer epinephrine 0.05 mcg/kg/min, inc by 0.02 mcg/kg/min as required. acceptable alternative is Dopamine 10 mcg/kg/min followed by epnephrine if efforts to reverse shock fail.
3) warm shock with low BP - answer norepinephrine 0.05 mcg/kg/min, inc 0.02 mcg/k/gmin as required
What should be done in the golden hour of a patient presenting with sepsis?
- recognize severe sepsis & shock
- Cardioresp monitors, insert IV
- Assess ABCs –> provide oxygen +/- non-invasive ventilation PRN (intubate if cannot protect airway, inadequate ventilation/oxygenation, potential for clinical deterioration)
- fluid resuscitate - push 20 cc/kg of isotonic fluids, up to 60 cc/kg and then consider vasoactive medications if fluid refractory shock –> reduced urine output, metabolic acidosis, signs of volume overload (cardiogenic shock), vital signs and peripheral perfusion do not improve
- consider adrenal insufficiency and administering hydrocortisone
- give abx in first hour
- treat hypoglycemia
- Call ICU!
True or false:
in order to be in septic shock, a patient has to have hypotension
Answer - false
- Septic shock is defined as “severe infection leading to cardiovascular dysfunction (including hypotension, need for tx with vasoactive medication, or impaired perfusion)
- Sepsis associated organ dysfunction in children as “severe infection leading to cardiovascular and/or noncardiovascular organ dysfunction”
- Derived from newly published guidelines by Weiss et al.
An 8-year-old boy with nephrotic syndrome who is currently receiving daily corticosteroids presents with a one-day history of being generally unwell, diffuse abdominal pain, and multiple episodes of vomiting. On initial assessment he appears Cushingoid, and his vital signs are: heart rate 140, respiratory rate 30, temperature 37.5°C, blood pressure 88/32. CRT is less than 2 seconds and peripheral pulses are easily palpated. The patient is confused and somewhat uncooperative. His abdomen is distended and diffusely sensitive to palpation, with mild involuntary guarding.
True or false - this patient should be given stress dose hydrocortisone over fluid resuscitation
Answer - False
- As per CPS statement, no gold standard exists for the diagnosis of acute adrenal insufficiency in the context of critical illness
- for this scenario, CPS said abstention from hydrocortisone therapy would be acceptable, but they also said this child may benefit from stress dosing of hydrocortisone (50 mg/m2; then 100 mg/m2 per day div 3-4 doses) early in the course pbefore progression to septic shock
- bottom line.. its controversial
A 10 year old child with history of IBD presents with watery diarrhea, 8-10 times per day, BP of 80/40, fever, and significant distention with rebound tenderness. What is the most appropriate treatment?
A. PO metronidazole 30 mg/kg/d div QID for 14 days AND IV vancomycin 40 mg/kd/g div QID
B. IV metronidazole 30 mg/kg/d div QID for 14 days AND PO vancomycin 40 mg/kd/g div QID
C. PO vancomycin 40 mg/kd/g div QID
D. PO vancomycin 40 mg/kd/g div QID and PR vancomycin 2g/day div QID
B. IV metronidazole 30 mg/kg/d div QID for 14 days AND PO vancomycin 40 mg/kd/g div QID. if complete ileus, add rectal vanco max 2g/d
*Vanco must be PO
Mild - no treatment <4 stools per day
Moderate > 4 stools = metronidazole 30 mg/kd/d div QID 10-14d
Severe - systemic toxicity (high grade fever) = vanco 40 mg/kg/d div WID x 10-14d
Severe + complicated (colitis, shock, peritonitis, ileus, megacolon, hypotension) = PO vanco + IV metronidazole x 10-14d. Add rectal vanco if ileus.
Which of the following statements are false?
- C diff colitis should be considered in a patient who received abx within the previous 12 weeks who has any diarrheal illness (watery or bloody)
- The relapse rate with treatmnent for C diff is 15-35%
- A patient who has been treated with a course of metronidazole PO previously who is now asymptomatic with persistent C diff + stool should be treated with a second course.
- Older age, exposure to multiple antibiotic classes, chemotherpy and history of GI surgery are all risk factors for C diff
- A patient who has been treated with a course of metronidazole PO previously who is now asymptomatic with persistent C diff + stool should be treated with a second course - false
* Treatment does not eradicate C difficile or the toxin from the stool. Asymptomatic patients, if tested, should not be treated again simply because the stool test is positive.
A healthy 10 month old previously treatment with C diff twice in the past now presents again with moderate symptoms with stool positive for C diff. The first episode was treated with metronidazole and the second with vanocmycin. What is the treatment now?
A. Repeat vancomycin course that was just given
B. Repeat regimen used for initial episode
C. vancomycin in a tapered or pulsed regimen
D. Consider other causes to explain clinical symptoms as patient is likely a carrier of C diff.
D. Consider other causes to explain clinical symptoms as patient is likely a carrier of C diff.
- Asymptomatic carriers: 15% to 63% of neonates, 3% to 33% of infants and toddlers younger than two years of age, and up to 8.3% of children older than two years of age
- Healthy infants under 1 year are not likely to have C diff diarrhea
- If patient was older
- First recurrence - tx repeat initial regimen or vancomycin
- Second recurrence - vanco in tapered or pulsed regimen
Routine head imaging is recommended for all infants born at…
A. < 33 weeks
B. < 32 weeks
C. < 31 weeks
D. < 30 weeks
< 32 weeks
(i.e. up to 31+6 weeks)
Do routine HUS on DOL 4-7
Which of the following are the risk factors for IVH in a preterm infant? (choose all)
A. Low birth weight (< 1kg)
B. Maternal corticosteroid use
C. Maternal chorioamnionitis
D. PDA
E. RDS
All except: maternal corticosteroid use (“lack of” Celestone is a risk factor).
Germinal matrix is fragile; fluctuation in cerebral blood flow increases risk of IVH
An infant born at 26+2 weeks underwent a screening head ultrasound on Day 5 of life, which showed unilateral Grade 2 IVH. When do you repeat head imaging?
A. Head ultrasound in 2 days
B. Head ultrasound in 7 days
C. Head ultrasound at 4 weeks post-birth
D. MRI at 4 weeks post-birth
E. MRI at corrected term
B. HUS in 7 days
- When first imaging is abnormal (Grade 2 or higher, white matter injury), repeat HUS in 7-10 days to detect complications (e.g. post hemorrhagic ventricular dilation).
- “HUS at corrected term” if < 26 weeks, or abnormal prior HUS (grade 3+) or additional risk factors.
- Routine term-corrected MRI not recommended; predictive value limited
- Who is NOT considered at high risk of influenza-related complications?
- 17 y/o F pregnant w/ first baby, in her first trimester
- 4 y/o F starting kindergarten this year
- 7 y/o M w/ well-controlled constipation
- 7 y/o M, healthy, Aboriginal living on reserve
c) 7 y/o M w/ well-controlled constipation
Which of the following patients has a contraindication to receiving LAIV this year?
- 17 y/o F w/ hx of GBS, 3 months after receiving flu vaccine
- 2 y/o F w/ an anaphylactic egg allergy
- 6 y/o M who completed a course of PO dex 2 weeks ago for an asthma exacerbation
- 4 y/o M on Flovent and Ventolin for asthma that has a wheeze
d. 4 y/o M on Flovent and Ventolin for asthma that has a wheeze
(LAIV contraindicated in
- Severe asthma
- defined as current active wheezing or currently on oral or high-dose inhaled glucocorticosteroids, or medically attended wheezing w/in previous 7 days)
Which patient has the correct dosing schedule for their very first flu vaccine?
- 1 y/o F LAIV 0.1 mL EN, 2 doses at least 4 weeks apart
- 9 y/o M IIV 0.5 mL IM, 2 doses at least 4 weeks apart
- 9 y/o M IIV 0.5 mL IM x 1
- 12 y/o F LAIV 0.1 mL EN, 2 doses at least 4 weeks apart
c. 9 y/o M IIV 0.5 mL IM x 1
- 1st year that a child < 9 years of age receives influenza vaccine (either IIV or LAIV), 2 doses at least 4 weeks apart required.
- If child <9 years of age has received >=1 dose of any influenza vaccine in the past, only 1 dose is required this season
- Children >=9 years only 1 dose / year
- 4 y/o M w/ an asthma exacerbation and concurrent influenza infection has just completed a course of Tamiflu and is being discharged from hospital. He received the LAIV 48h prior to his symptom onset. What is the next best step in regards to influenza vaccination?
- He has received the LAIV and is covered for the season; no further action required
- Schedule a follow-up in your clinic to determine whether he has developed any further flu-like symptoms
- Give another dose of LAIV at least 48h after the course of Tamiflu is completed
- Give LAIV prior to discharge to ensure he is covered
c. Give another dose of LAIV at least 48h after the course of Tamiflu is completed
LAIV should not be administered until 48 h after d/c of antiviral agents, as these will inactivate vaccine virus.
If anti-influenza agent must be given w/in 2 weeks after receipt of LAIV, another dose should be given >= 48 h after d/c of therapy or give IIV.
- For which infant would hydrocortisone to prevent or treat BPD be recommended?
- 29 wk GA, uncomplicated pregnancy and delivery, for prevention
- 26 wk GA infant, maternal chorioamnionitis, starting in 1st 24-48h after birth
- Ex-28 week GA infant on ventilator for 2 weeks with evolving BPD
- 32 wk GA infant on O2 for treatment of BPD
b. 26 wk GA infant, maternal chorioamnionitis, starting in 1st 24-48h after birth
(high risk: <28 weeks GA, maternal chorioamnionitis)
- Ex-27 week GA male infant in the NICU remains ventilated after 1st week post-birth w/ increasing oxygen requirements and worsening lung disease. What treatment could be considered for BPD?
- Inhaled corticosteroid
- Corticosteroid mixed with surfactant via ET tube
- Hydrocortisone 1 mg/kg per day x 7 days, then 0.5 mg/kg per day x 3 days
- Dexamethasone starting with 0.15 - 0.2 mg/ kg/day, tapered over a short course
d. Dexamethasone starting with 0.15 - 0.2 mg/ kg/day, tapered over a short course
An ex-27+2 GA infant, who was exposed to chorioamnionitis in utero, is admitted to the NICU and has just completed a course of hydrocortisone for prevention of BPD. Which of the following statements is true?
- He may be at increased risk for late-onset sepsis
- The hydrocortisone can be safely combined w/ indomethacin prophylaxis
- Hydrocortisone prophylaxis was not appropriate for this patient as he had no risk factors for BPD
- He may be at risk for a prolonged NICU stay
a. He may be at increased risk for late-onset sepsis
Which of the following is recommended to prevent BPD?
- Dexamethasone
- Inhaled corticosteroids
- Intubation
- None of the above
d. None of the above
For prevention, for infants at highest risk for BPD (e.g., <28 weeks GA or exposed to chorioamnionitis)
- May consider prescribing hydrocortisone (physiologic replacement dose: 1 mg/kg/day x 7 days, then 0.5 mg/kg/day x 3 days) starting in 1st 24 to 48 h after birth
Which of the following is recommended in treating an acute covid-19 infection in pediatrics?
- Anti-virals
- Steroids
- Antibiotics
- Supportive care
Answer 4 - supportive care
- there is no proven treatment at this time for covid-19 in pediatrics
- recommend AGAINST use of off-label/investigational studies therapies, as well as anti-virals at this time
- risk of secondary bacterial infxn is low, so abx is not recommended
- Supportive care recommended at this time
Children/youth comprise a minority if cases of COVID-19 cases in high/middle income countries and their diseases tends to be milder.
True or false:
Suspected reasons for less symptoms in children include possible differences in ACE-2 receptor expression and blunting of inflammatory responses.
True
True or false
Mortality in adults is due to ARDS and multi-organ dysfunction
True
COVID-19 transmission in the pediatric population is from:
- Person to person spread
- Asymptomatic carriers
- Airborne transmission
- Options 1 & 2
Answer 1 - person to person spread
- Major risk factor is thought to be from household exposures
- Note: overall contribution of asymptomatic children to overall transmission remains unclear
Current recommendations on general health measures and prevention strategies for covid 19 include:
- Wearing a mask, ensuring to practice hand hygiene before/after masking and avoiding touching the mask
- Physical distancing
- Keep routine & booster vacinations up to date
- All of the above
Answer - 4 all of the above
True or false:
MIS-C / PIMS is due to an acute infection with COVID-19.
Answer - false
- MIS-C/PIMS is a post-infectious inflammatory syndrome that typically occurs 3-6 weeks after an acute infection
- Studies have shown that children usually negative for SARS-COV-2 on RT-PCR but test positive for antibodies
Which of the following is NOT considered a distinguishing feature of PIMS/MIS-C (compared to KD):
- Children with PIMS/MIS-C tend to be older in age at presentation compared to KD
- MIS-C disproportionately affects children who are Caucasian, whereas children with KD typically are East Asian
- MIS-C tends to have significant cardiac dysfunction and prominent GI features compared to KD
- MIS-C tends to have higher inflammatory markers compared to KD
Answer 2
- PIMS/MIS-C disporportionately affects African/Afro-Carribean ethnicity
Which of the following is NOT a biochemical hallmark of PIMS/MIS-C?
- Thrombocytopenia
- Elevated WBC count
- Elevated CRP
- Hypoalbuminemia
Answer 2 - elevated WBC count
- typically you see low WBC and elevated neutrophils
True or false:
CPS describes PIMS/MISC presenting in one of 4 ways, which helps guide management.
Answer - false
- CPS describes PIMS/MISC presenting in 1 of 3 ways –> 1) Fever & hyperinflammation 2) KD 3) shock & shock-like states
Management of PIMS-MISC includes all of the following, EXCEPT:
- IVIG
- Corticosteroids
- Anakinra
- Rituximab
Answer 4 - Rituximab
- Biologic agents including IL-1 inhibitors (e.g. Anakinra) may be considered in some cases (e.g. complicated KD presentation, MAS, KDSS)
What are risk factors for neonatal HSV?
Newly acquired maternal infection
- First episode of primary infection (up to 60% risk transmission)
- 1st episode of nonprimary infection (<30% risk transmission)
PROM
Instrumentation (forceps, vacuum)
C/S reduces risk
What is the best diagnostic test for neonatal HSV?
PCR testing of CSF, skin lesions, mucous membranes and blood is thought to be more sensitive
**CSF PCR could be falsely negative within 24-48h of illness. If index of suspicion is high, repeat within 72h of starting acyclovir
How and when does neonatal HSV present?
In most cases, the initial symptoms of NHSV infection present within the first four weeks of life. Occasionally, disease presents for the first time between four and six weeks after birth.
Disseminated HSV (multiple organs eg. liver and lung);
Localized CNS HSV;
Skin, eye and mucous membrane (SEM) infection
Neonate with fever and irritability, mother has suspected first episode genital HSV at delivery.
Management if vaginal delivery?
C/S?
Vaginal delivery OR C/S with ROM prior to C/S:
- swab mouth, nasopharynx, conjunctiva (controversial at birth or at 24h) before ACV
- Prophylaxis IV ACV x 10 days
- If positive swab, then blood and CSF PCR. If blood/CSF +, 21d treatment. If blood/CSF neg, then 14d ACV.
C/S without ROM:
- swab mouth, nasopharynx, conjunctiva at 24h
- If positive, readmit for CSF and blood, transaminases, then 14d ACV if blood/CSF neg and 21d if blood or CSF positive
- If negative, observe
Duration of tx for neonatal HSV and things to monitor?
IV 60 mg/kg/d div q8h
Skin/eye/mucous membranes - 14d
CNS or disseminated (blood or CNS +ve) - 21d
- CSF should be sampled near end of 21 days and extended with weekly CSF sampling until negative PCR -> then d/c acyclovir
- Suppressive therapy with oral ACV (300 mg/m2 per dose TID) should be given for six months to infants with CNS disease
Monitoring
Monthly CBC and renal function - Neutropenia + nephrotoxicity
Neurodevelopment, ophthalmologic, hearing
What are warning signs that should trigger further evaluation for CP?
1) Hand preference <12 months of age
2) Fisting persistent > 4 mo
3) asymmetries in movement or posture
4) Stiffness or tightness in legs <12 mo
5) inability to sit by 9 mo
Treatment for lyme disease
Which of the following statements are true?
- If the mother is + for covid and the newborn has respiratory distress, the most likely etiology is also covid.
- The is very low risk for vertical transmission for COVID
- NICU resus team attendance is required if the mother has confirmed COVID
- If the mother is + for covid, droplet/contact precautions during the initial steps of resuscitation is strongly recommended, particularly with CPAP/PPV and during intubation
- If the mother is + for covid and the newborn has respiratory distress, the most likely etiology is also covid. - FALSE
- The is very low risk for vertical transmission for COVID - TRUE
- NICU resus team attendance is required if the mother has confirmed COVID - FALSE
- If the mother is + for covid, droplet/contact precautions during the initial steps of resuscitation is strongly recommended, particularly with CPAP/PPV and during intubation - TRUE
True or false?
- If the mother has severe covid requiring respiratory support, the resus team should wear an N95 mask and eye protection for AGMP procedures for the infant
- If the mother has COVID, delayed cord clamping should be avoided to avoid exposing the infant to possible COVID
- If the mother has severe covid requiring respiratory support, the resus team should wear an N95 mask and eye protection for AGMP procedures for the infant - TRUE
- If the mother has COVID, delayed cord clamping should be avoided to avoid exposing the infant to possible COVID - FALSE. low risk with delayed cord clamping and benefit outweights risk
A 4 year old child presents with severe stridor and respiratory distress suggestive of croup. Their covid swab was positive 2 days ago. Unfortunately, there is a PPE shortage and no more airborne rooms available. What would you do for management?
- Give ventolin via MDI + aerochamber
- Give oral corticosteroids (dex)
- Give oral dex with MDI, IM or SC epinephrine
- Give oral dex and nebulized epinephrine
- Call social work
Croup and COVID
For moderate to severe croup, administer oral corticosteroids (dex 0.6 mg/kg, max 16 mg/dose).
For severe croup, nebulized epi provided that full PPE available and airborne precautions can be taken
Alternatives include MDI, SC or IM
An MDI for epinephrine delivery has been urgently approved by Health Canada, but the evidence is extremely limited for use in croup. Equivalent dosing is extrapolated from limited studies - current recommendations suggesting 2 puffs for infants under 1 year of age, and 4 puffs for older children. Repeat dosing q15 min based on clinical assessment
In settings where all airborne precautions cannot be taken, delivering epinephrine SC or IM may be considered, with dosing based on weight, as follows:
7.5 to 15 kg: 0.1 mg IM/SC
15 to 30 kg: 0.15 mg IM/SC
>30 kg: 0.3 mg IM/SC
In the management of pediatric COVID, which of the following therapies are supported by evidence?
- Dexamethasone
- IVIG
- Antiviral treatment
- Tocilizumab
- None of the above
None of the above are supported by evidence
Symptomatic – O2, NG or IV hydration when unable to tolerate PO
Some early concerns about ibuprofen use increasing risk for COVID-19 mortality and morbidity are not supported by evidence, and current therapeutic practice continues to be recommended
In cases of severe disease, additional pressure and ventilatory support may be required, including intubation
If evidence for a secondary infection, antibiotics should be administered pre-emptively
For sepsis, IV 3rd gen cephalosporin +IV vancomycin for severe disease
For pneumonia, intravenous ampicillin or oral amoxicillin
What is NOT considered an AGMP?
- HFNC
- Oxygen
- Bag mask
- CPAP
- Intubation
- Suction
Answer - 2 Oxygen (all the other ones are considered AGMP)
In which of the following situation, is the use of adjuvant corticosteroids recommended for the treatment with meninigtis?
A. 3 week old term female with suspected GBS meningitis
B. 5 year old male with VP-shunt presenting with change in LOC, suspected meningitis
C. 8 year old unimmunized female with meningitis, CSF gram stain showing gram-negative coccobacilli
D. 6 year old partially immunized male with meningitis, CSF gram stain showing gram-negative cocci
E. 3 year old female with confirmed meningococcal meningitis
Answer: C
Use adjuvant steroids if:
CSF gram stain shows coccobacilli consistent with H. influenzae;
or presumptive S pneumoniae meningitis
Continue steroids for 4 days if H. influenzae/S. pneumo confirmed, discontinue within 48 hours if other pathogen
List the following pathogens from the shortest to the longest recommended duration of antibiotics for meningitis treatment
GBS
S. pneumoniae
H. influenzae
N. meningitidis
N. meningitidis = 5-7 days
H. influenzae = 7-10 days
S. pneumoniae = 10-14 days
GBS = 14-21 days
Remember “NHS, GBS”